Galectin-3 as a new thrombotic risk factor in patients with atrial fibrillation

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ana Maria Merino Merino

University Hospital of Burgos, Burgos (Spain)

15 More presentations in this session

Presentation thumbnail

Relationship between interatrial septum motion and persistent atrial fibrillation recurrence after catheter ablation

Doctor H. Kobayashi (Matsumoto, JP)

Presentation thumbnail

The association between the severity of sleep apnea and atrial remodeling with atrial fibrillation

Doctor K. Nakamura (Tokyo, JP)

Presentation thumbnail

The relationship between left atrial fibrosis and left ventricular diastolic dysfunction in paroxysmal atrial fibrillation

Doctor T. Gizatulina (Tyumen, RU)

Abstract Slides

Presentation thumbnail

Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at MRI and low voltage areas in patients with persistent atrial fibrillation

Doctor J. Chen (Nanjing, CN)

Abstract Slides

Presentation thumbnail

Correlation of left atrial low voltage and fractionation substrate between sinus rhythm and atrial fibrillation: high density mapping of the arrhythmogenic substrate in patients with persistent AF

Doctor J. Chen (Nanjing, CN)

Abstract Slides

Access the full session

Session thumbnail

Poster session 2 - Atrial Fibrillation - Pathophysiology and Mechanisms

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on stroke prevention in atrial fibrillation

Congress Presentation

Treatment strategies for atrial fibrillation in heart failure - discussion

Congress Presentation

We really need long-term cardiac rhythm monitoring after embolic stroke of unknown source - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources